Introduction
============

*Acinetobacter baumannii* is an important healthcare-associated pathogen that can cause of life threatening infections ([@B38]; [@B23]). *A. baumannii* is the second most common multidrug-resistant cause of nosocomial infection in burn patients in Iran ([@B1]; [@B4]). Its infections have become critical challenge to health care systems due to increasing levels of resistance to antimicrobial agents in nosocomial isolates of *A. baumannii* ([@B12]; [@B36]). In developing countries, including Iran, the occurrence of carbapenem non-susceptinle *A. baumannii* (CNSAb) infections is a growing problem in hospitalized burn patients ([@B35]; [@B55]). Inadequate management of the antibiotic therapy of CNSAb infections often leads to the emergence of extensive and pandrug resistant (XDR and PDR) CNSAb strains, which present significant health challenges by prolonging hospitalization, treatment failures, and increased mortality ([@B32]). The most important mechanism of carbapenem resistance in *A. baumannii* is the production of carbapenem-hydrolyzing β-lactamases of Ambler classes A, B, and D. In addition to being resistant to all β-lactams available, carbapenemases have a high capacity to spread, since their genes have been commonly found in transferable plasmids containing integrons and insertion sequence (IS) elements ([@B30]).

Worldwide surveillance has shown that the global population structure of CNSAb isolates is diverse, but a small number of widespread clones, including the international clonal (IC) lineage I--III, also defined based on multilocus sequence typing (MLST) as clonal complexes (CC), may be predominant in healthcare settings ([@B29]). Multilocus variable-number tandem-repeat (VNTR) analysis (MLVA) has been considered as a rapid and cost-effective method for fine-scale typing of *A. baumannii*, enabling inter-laboratory comparison of typing data ([@B30]). A recent study found the high discriminatory power of MLVA, sufficient to detect diversity among isolates showing identical MLST types ([@B2]).

Up-to-date surveillance information regarding genotypic spread, plus local antimicrobial susceptibility patterns of clinical isolates of *A. baumannii*, are necessary for effective drug therapy and control of XDR and PDR *A. baumannii* hospital outbreaks ([@B21]). Considering the points mentioned above, the aim of this study was to determine molecular epidemiology, to identify the dissemination of the most common resistance genes, to investigate the prevalence of integrons and arrangement of integron gene cassettes among CNSAb isolates from a referral burn center in Tehran, Iran.

Materials and Methods {#s1}
=====================

Bacterial Isolates
------------------

A total of 92 non-repetitive *A. baumannii* strains were collected between January 2012 to May 2013, from the burn wound infections of hospitalized patients in Shahid Motahari hospital, the only referral burn center in Tehran, Iran. Species of these isolates were initially characterized using the API20NE system (bioMérieux, Marcy-l'Etoile, France) and then final identification of isolates were performed by multiplex PCR using *gyrB*-directed primers according to the study of [@B26].

Antimicrobial Susceptibility Tests and Biofilm Formation Assay
--------------------------------------------------------------

The Clinical and Laboratory Standards Institute (CLSI) guideline ([@B16]) for minimum inhibitory concentrations (MICs) using the E test was used to assess the susceptibility of 92 *A. baumannii* isolates to imipenem (Ezy MIC^TM^ strips, Himedia, India). All isolates with MICs of imipenem \>4 mg/L were defined as CNSAb isolates and were recruited for further screening ([@B16]).The susceptibility of CNSAb isolates to 17 other antimicrobial agents such as amikacin, ampicillin-sulbactam, cefepime, ceftazidime, ciprofloxacin, colistin, gentamicin, levofloxacin, meropenem, minocycline, piperacillin, piperacillin-tazobactam, rifampicin, tetracycline, tigecycline, tobramicin, and trimethoprim-sulfamethoxazole were also carried out using the E test (Ezy MIC^TM^ strips, Himedia, India). The phenotypic presence of Metallo-β-lactamase (MBL) enzymes was detected by imipenem/imipenem + EDTA strips (Ezy MIC^TM^ strips, Himedia, India). The MIC ratio of MBL-E test of ≥8 mg/L was interpreted as indicative of MBL activity, according to the manufacturer's instructions. Since there is no breakpoint for tigecycline and rifampicin against *A. baumannii* strains in the CLSI guidelines; therefore, the criteria for interpretation of the MIC values of tigecycline (MIC of ≤1 mg/L defined as susceptible and \>2 mg/L as resistant) were determined according to the European committee on antimicrobial susceptibility testing (EUCAST) ([@B20]) for members of the *Enterobacteriaceae sp*. and CLSI criteria, using breakpoint values suggested for *Staphylococcus aureus* applied to rifampicin (susceptible defined as ≤1 mg/L and resistant defined as ≥4 mg/L). The MIC~50~ and MIC~90~ of each antibiotic were calculated. *Escherichia coli* ATCC 25922, *Pseudomonas aeruginosa* ATCC 27853, and *E. coli* ATCC 35218 were used as quality control organisms. The phenotype of *A. baumannii* is defined as MDR and XDR according to the International Expert proposal for Interim Standards Guidelines ([@B34]). The formation assay and quantitative analysis of biofilm were performed according to a previous study ([@B54]).

Molecular Detection of β-lactamases-encoding Genes and Characterization of Integrons
------------------------------------------------------------------------------------

A series of PCR amplifications were done for detection of different Ambler class *bla* gene groups: class A; *bla*~PER-1~, *bla*~V\ EB-1~, *bla*~CTX-M~, *bla*~KPC~, *bla*~GES~, *bla*~TEM~ and *bla*~SHV\ -1~ ([@B42]; [@B19]; [@B9],[@B10]; [@B43]; [@B46]; [@B15]); Class B, *bla*~IMP-1~, *bla*~V\ IM-2~, *bla*~GIM-1~, *bla*~SPM-1~ *bla*~SIM-1~ and *bla*~NDM-1~ ([@B14]); Class C, *bla*~ADC~ ([@B11]) and Class D, *bla*~OXA-23~-, *bla*~OXA-40~-, *bla*~OXA-51~-, *bla*~OXA-58~ ([@B52]) and *bla*~OXA-143~-like ([@B25]) encoding genes were detected. To determine whether IS*Aba1* was present upstream of *bla*~OXA-23~-like, *bla*~OXA-51~-like ([@B51]) and *bla*~ADC~ ([@B24]) genes, PCR mapping experiments were performed. Detection and characterization of class 1, 2, and 3 integrons, as well as gene cassette mapping and sequencing of class 1 integrons were carried out using previously described PCR assay ([@B18]).

Genetic Diversity and Population Structure
------------------------------------------

The IC lineage so-called PCR-based group were identified using three-locus dual assay multiplex PCR as described previously ([@B50]). Isolates pertaining to the novel variant of the PCR-based group, according to the new combination of amplified products obtained from the two separate multiplex PCRs, did not correspond to those previously defined. Moreover, the CNSAb isolates were genotyped using the MLVA-8 scheme method developed by [@B44]. For clustering analysis, the allele strings were entered into the BioNumerics software v.7.0 (Applied Maths, Sint-Martens-Latem, Belgium) as character values. A cut-off value of 90% similarity was applied to define clusters ([@B37]). MLST was performed according to the Bartual method described previously ([@B8]). Allele sequences, sequence types (STs), primer sequences and other details are available from the MLST website at <http://pubmlst.org.> The minimum spanning tree (MSTree) algorithm was used to predict the clonal relationship between all CNSAb isolates. MSTree algorithm was constructed with the BioNumerics software v.7.0 (Applied Maths, Sint-Martens-Latem, Belgium) using a categorical coefficient according to a previous report ([@B47]).

Statistical Analysis
--------------------

Statistical analyses were performed by Student's *t*-test, Fisher's exact test and the chi-square test with the SPSS software package (version 16). *P*-values \<0.05 in all experiments were considered as significant.

Results
=======

Antibiotic Susceptibility Testing and Biofilm Assay
---------------------------------------------------

In this study, from the 92 *A. baumannii* isolates, 69 isolates were confirmed as CNSAb. The MIC determination of all CNSAb isolates, exhibited non-susceptibility rates ≥95% to cefepime, ceftazidime, levofloxacin, meropenem, piperacillin, piperacillin-tazobactam, rifampicin and trimethoprim-sulfamethoxazole (**Table [1](#T1){ref-type="table"}**). CNSAb isolates showed high susceptibility to colistin (100%), tigecycline (87%) and minocycline (69%) with MIC~50~ values of 0.01, 0.25, and 5 mg/L, respectively and MIC~90~ values of 1, 3, and 10 mg/L, respectively (**Table [1](#T1){ref-type="table"}**). Fifty-three (77%) CNSAb isolates revealed XDR phenotypes. In all XDR isolates following colistin with 100% sensitivity, tigecycline (83%) and minocycline (67%) were the most effective antibiotics. Fifty-six (81%) of all CNSAb isolates formed strong biofilm whereas 13 (19%) of these isolates were considered as weak biofilm forming strains. Our study revealed a significant association of strong biofilm formation with antimicrobial resistance (*P* = 0.0001).

###### 

The minimum inhibitory concentration (MIC) distribution of 18 antimicrobial agents for the 69 CNSAb isolates as determined by E test.

  Antimicrobial agents^a^   MIC (μg/mL)          Non-susceptible (%)              
  ------------------------- -------------------- --------------------- ---------- -----
  CST                       0.016 to 2           0.01                  1          0
  IPM                       ≤8 *to* ≥ 128        12                    32         100
  MEM                       ≤8 *to* ≥ 256        24                    48         97
  PIP                       5 *to* ≥ 240         ≥240                  ≥240       99
  TZP                       0.01 *to* ≥ 240      120                   ≥240       96
  SAM                       2/1 *to* ≥ 256/128   32/16                 ≥256/128   65
  CAZ                       4 *to* ≥ 256         128                   ≥256       96
  FEP                       4 *to* ≥ 256         128                   ≥256       97
  CIP                       0.1 *to* ≥ 240       30                    60         95
  LVX                       0.5 *to* ≥ 240       10                    60         95
  TET                       1 *to* 120           5                     30         39
  MIN                       0.1 to 60            5                     10         31
  TGC                       0.023 to 32          0.25                  3          13
  TOB                       1 *to* ≥ 240         30                    120        66
  GEN                       2 *to* ≥ 240         30                    120        93
  AMK                       8 *to* ≥ 256         64                    256        86
  SXT                       5 *to* ≥ 240         30                    60         99
  RIF                       0.1 to 120           10                    30         97

a

AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CST, colisitin; FEP, cefepime; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; PIP, piperacillin; RIF, rifampicin; SAM, ampicillin-sulbactam; SXT, trimethoprim- sulfamethoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramicin; TZP, piperacillin-tazobactam.

Detection of Antibiotic Resistance Determinants
-----------------------------------------------

Phenotypic detection of MBL showed that none of the isolates were positive for MBL. The presence of *bla*~OXA51~-like and *bla*~ADC~ were confirmed in all CNSAb isolates. The high prevalence of *bla*~OXA-23~-like (53; 77%) and *bla*~PER-1~ (37; 54%) were seen in CNSAb isolates. Co-existence of *bla*~OXA-23~-like/*bla*~OXA-40~-like and *bla*~OXA-23~-like/*bla*~OXA-58~-like genes were detected in 6 (9%) and 2 (3%) of the isolates, respectively. The PCR results were negative for the other β-lactamase encoding genes including *bla*~OXA-143~-like, *bla* MBL (*bla*~IMP-1~, *bla*~V\ IM-2~, *bla*~GIM-1~, *bla*~SPM-1~ *bla*~SIM-1~ and *bla*~NDM-~), *bla*~CTX-M~, *bla*~KPC~, *bla*~GES~ *bla*~TEM~ and *bla*~SHV\ -1.~ IS*Aba*1 was detected upstream of *bla*~ADC,~ *bla*~OXA-23~-like, and *bla*~OXA51~-like genes in 67 (97%), 29(42%), and 18 (26%) of CNSAb isolates, respectively (**Figure [1](#F1){ref-type="fig"}**). A significant correlation was observed between the presence of IS*Aba*1 in upstream of *bla*~OXA-23~-like and increasing MIC of imipenem (MIC ≥ 16 mg/L) (*P* = 0.042). In the presence of IS*Aba*1 in upstream of *bla*~OXA-51~-like and increasing imipenem MICs, there was no significant correlation (*P* = 0.347).

![**Dendogram shows the genetic diversity of 69 carbapenem non-susceptible *Acinetobacter baumannii* isolates by MLVA and MLST; carbapenemase encoding genes; MIC ranges of colisitin, imipenem, and tigecycline; resistance phenotype; biofilm formation and international clonal lineage**.](fmicb-06-01146-g001){#F1}

Class 1 integron gene cassettes were identified in 58 (84%) CNSAb isolates while class 2 and 3 integrons were not found. Six different cassette combinations were detected within the class 1 integrons. The most prevalent cassette combination, *aac*A4-*cat*B8-*aad*A1 (2.3 Kb), were detected in 23 (39%) of class 1 integrons. The other cassette combinations including *arr3-aacA4* (1.3 Kb), *aacC1-orfX-orfX'-aadA1* (2.5 Kb), *orfI-aadA1* (1.5 Kb), *dfrVII* (0.7 Kb) *and dfrXII-orfF-aadA2* (1.7 Kb) were detected in 10 (14.5%), 9 (13%), 7 (10%), 7 (10%), and 2 (3%) CNSAb isolates, respectively. The gene cassette arrangement showed that the class 1 integrons harbor genes encoding resistance to aminoglycosides, chloramphenicol, rifampicin and trimethoprim/sulfamethoxazole. Also, the results of this study show that integron-associated β-lactamases encoding genes were not detected in class 1 integrons-harboring CNSAb isolates.

Genetic Diversity and Population Structure
------------------------------------------

Three-locus dual assay multiplex PCR showed eight different PCR-based groups (G1, G2, G6, G9, G10, and G15--G17) among the 69 CNSAb isolates. Twenty-five (36%) and 13 (19%) CNSAb isolates belonged to G1 (IC II) and G2 (IC I), respectively. Based on the variations in combination of PCR amplicons of the *bla*~OXA-51~-like, *csuE* and *ompA* genes, 31(45%) of the CNSAb isolates belonged to 6 IC variants PCR-based groups (**Table [2](#T2){ref-type="table"}**). G9 (14; 45%) was the most common IC variant (**Table [2](#T2){ref-type="table"}**).

###### 

Combinations of amplicons obtained in the dual multiplex PCRs used to describe 31 *A. baumannii* IC variants.

  Variant type   PCR group 1   PCR group 2                  
  -------------- ------------- ------------- ---- ---- ---- ----
  G 6^a^ (1)     \-            \-            \-   \+   \-   \-
  G 9 (14)       \-            \-            \+   \+   \-   \+
  G 10 (2)       \-            \+            \-   \+   \+   \-
  G 15 (2)       \+            \-            \-   \-   \-   \+
  G 16 (10)      \-            \+            \-   \+   \-   \-
  G 17 (2)       \+            \-            \+   \-   \-   \+

a

G; PCR-based group.

The MSTree algorithm of the MLST data of this study suggests that 40 previously known STs combined into four CC (**Figure [2](#F2){ref-type="fig"}**). Thirty-six (52%) and 13 (19%) of all 69 CNSAb isolates belonging to CC-92 and CC-405, respectively. According to the MSTree algorithm, only one singleton ST (ST345) was identified (**Figure [2](#F2){ref-type="fig"}**). ST118 was the predominant ST, comprising 17.3% of isolates.

![**The minimum spanning tree (MStree) was constructed using a categorical coefficient based on multilocus sequence typing (MLST) data.** Each circle stands for a different sequence type (ST). The color of a circle and the line clustering the ST with the same color represents an identical ST. Size of the circle corresponds to the number of isolates. The width of the line reflects the genetic distance between ST (heavy and thin lines represent a difference in one allele and two or more alleles, respectively).](fmicb-06-01146-g002){#F2}

By the MLVA typing method, the 69 CNSAb isolates were grouped into 56 distinct MLVA types with 6 clusters and 53 singleton genotypes. Loci MLVA-AB_0845 was absent (N) in all studied isolates. In this study, the VNTR loci MLVA-AB_3002 and MLVA-AB_2240 displayed lower diversity, whereas VNTR loci MLVA-AB_2396 and MLVA-AB_3468 showed higher level of diversity.

Thirty STs corresponded to 30 MLVA types; other STs (118, 95, 75, 227, 405, 231, 788, 225, 227, and 133) included heterogeneous MLVA profiles (**Figure [1](#F1){ref-type="fig"}**).

In this study, IC variants were classified into 23 STs belonging to CC92, CC405, CC227, CC225 and one singleton (**Figure [1](#F1){ref-type="fig"}**).

Relationship between IC Lineages with Antibiotic Resistance Determinants
------------------------------------------------------------------------

**Table [3](#T3){ref-type="table"}** shows the frequency of antibiotics resistance in two major epidemic lineages and IC variants. Susceptibility to all antimicrobial agents, except tobramicin, in isolates belonged to IC II was higher than the IC I and IC variants (**Table [3](#T3){ref-type="table"}**). It is noteworthy that the IC variants had the highest resistance rate to tigecycline (7; 22.5%) with MIC~50~ and MIC~90~ of 0.25 and 3 mg/L, respectively (**Tables [1](#T1){ref-type="table"}** and **[3](#T3){ref-type="table"}**). Among the 13 carbapenem non-susceptible IC I, 12 (92%) were XDR while this rate was 14 (56%) and 27 (87%) in the isolates belonging to the IC variants and IC II, respectively. The resistance to beta lactam antibiotics in IC I and IC variant isolates was higher than that in IC II. Thirty-one (100%) IC variants and 22 (88%) of the IC II population formed strong biofilm but only 3 (23%) of IC I had this characteristic. In the present study, resistance to antimicrobials was comparatively higher among IC variant than IC I and IC II CNSAb isolates (*P* = 0.0012 and *P* = 0.0001, respectively). A slightly higher susceptibility to antimicrobials was observed in IC II than IC variants and IC I (*P* \> 0.05). Our analysis revealed a significant correlation (*P* = 0.003) between the presence of *bla*~PER1~and biofilm formation in the CNSAb isolates. The CNSAb isolates belonging to all clones had the *bla*~OXA-23~-like gene. All CNSAb isolates classified in IC I, were positive for the *bla*~OXA-23~-like gene (**Table [4](#T4){ref-type="table"}**). According to **Table [4](#T4){ref-type="table"}**, the frequency of IS*Aba*1/*bla*~OXA-23~-like and *bla*~PER-1~ genes in a population belonging to IC variants were significantly higher than IC I and IC II (*P* = 0.027 and *P* = 0.003, respectively). **Table [4](#T4){ref-type="table"}** shows that the distribution of different types of class 1 integrons is related to major epidemic lineages with predominance of class 1 integrons belonging to type 2.

###### 

Frequency of antimicrobial non-susceptibility in three major epidemic lineages in the 69 CNSAb isolates.

               \% Non-susceptibility to CLSI antimicrobial groups^a^                                                                                           
  ------------ ------------------------------------------------------- ----- ----- ---- ---- ---- ----- ----- ----- ----- ----- ---- ---- ---- ----- ----- --- -----
  IC1 (13)     100                                                     100   100   85   92   62   92    100   100   100   100   48   46   9    100   100   0   100
  IC2 (25)     100                                                     92    88    48   84   76   88    88    96    92    96    19   32   5    88    96    0   92
  V (31)       100                                                     100   100   61   84   61   100   97    100   97    100   25   39   24   97    100   0   97
  Total (69)   100                                                     97    96    65   86   66   93    95    99    96    97    31   39   13   95    99    0   97

a

Considerations in the assignment of agents to Groups A, B, and C include clinical efficacy, prevalence of resistance, minimizing emergence of resistance, cost, FDA clinical indications for usage, and current consensus recommendations for first-choice and alternative drugs.

Group A

are considered appropriate for inclusion in a routine, primary testing panel, as well as for routine reporting of results for the specific organism.

Group B

comprises agents that may warrant primary testing.

Group O

(Other) includes agents that have a clinical indication for the organism.

Escherichia coli

ATCC25922 and

Pseudomonas aeruginosa

ATCC27853 were used for quality control of antimicrobial susceptibility testing and included in each run.

b

IC, international clonal lineage; V, IC variants; AMK, amikacin; CAZ, ceftazidime; CIP, ciprofloxacin; CST, colisitin; FEP, cefepime; GEN, gentamicin; IPM, imipenem; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; PIP, piperacillin; RIF, rifampicin; SAM, ampicillin-sulbactam; SXT, trimethoprim- sulfamethoxazole; TET, tetracycline; TGC, tigecycline; TOB, tobramicin; TZP, piperacillin-tazobactam.

###### 

Frequency of antimicrobials resistance determinants in epidemic clonal lineages of the CNSAb isolates.

  IC^a^ (No.)   Ambler classification No. (%)   IS*Aba* upstream beta-lactamase encoding genes No. (%)   Class 1 integron No. (%)   Class 1 integron types^b^ No. (%)                                                                                                           
  ------------- ------------------------------- -------------------------------------------------------- -------------------------- ----------------------------------- -------- ------- --------- --------- ---------- --------- -------- --------- ------- -------- --------- --------
  IC-I (13)     4 (31)                          3 (23)                                                   13 (100)                   2 (15)                              3 (23)   1 (8)   4 (31)    5 (39)    13 (100)   9 (69)    \-       6 (46)    \-      2 (15)   1 (8)     \-
  IC-II (25)    10 (40)                         4 (16)                                                   17 (68)                    2 (8)                               1 (4)    0       7 (28)    7 (28)    24 (96)    19 (76)   1 (4)    8 (32)    \-      3 (12)   4 (16)    3 (12)
  V (31)        24 (77)                         6 (19)                                                   24 (77)                    5 (16)                              2 (6)    1 (3)   18 (58)   6 (19)    30 (97)    30 (97)   6 (19)   9 (29)    2 (6)   4 (13)   5 (16)    4 (13)
  Total (69)    48 (69)                         13 (19)                                                  54 (78)                    9 (13)                              6 (9)    2 (3)   29 (42)   18 (26)   67 (97)    58 (84)   7 (10)   23 (33)   2 (6)   9 (13)   10 (14)   7 (10)

a

Abbreviations: IC, international clone; V, variants of IC.

b

Type 1, orfI-aadA1; Type 2, aacA4-catB8-aadA1; Type 3, dfrXII-orfF-aadA2; Type 4, aacC1-orfX-orfX'-aadA1; Type 5, arr3-aacA4; Type 6, dfrVII.

Discussion
==========

Nosocomial infections caused by CNSAb are currently among the most difficult to treat. The control of CNSAb infections among hospitalized patients continues to present serious challenges to patient management in developing countries like Iran ([@B17]; [@B22]; [@B7]). The main challenge remains choosing the most likely effective antibiotics as determined by *in vitro* testing of antibiotics, based on the local susceptibility patterns ([@B21]). Overall, the findings of this study are consistent with recent studies from Iran that show an alarming trend of CNSAb increase and in MDR *A. baumannii* resistance against a wide spectrum of antimicrobial agents ([@B36]). However, in the present study colistin, tigecycline, and tetracyclines exhibited a potent activity against CNSAb isolates. Our data revealed a decrease (10%) of resistance in CNSAb isolates to tigecycline ([@B7]), likely due to the implementation of restriction policy on the empirical prescription of tigecycline. Decrease in antibiotic resistance after implementation of restriction policies have been shown in several reports ([@B3]; [@B49]). Our finding of positive association in strong biofilm formation and resistance to antimicrobial is consistent with a recent report ([@B5]). This could be due to inadequate penetration of the antimicrobials into the biofilms, and the emergence of persister cells in the biofilms ([@B39]).

The findings of our study on IS*Aba*1 elements upstream of *bla*~OXA~ genes and their role as a promoter to enhance OXA--enzymes expression and MIC of imipenem confirms previous reports ([@B31]); however, this finding are in contrast to a recent report by [@B41] from Iran. Not only did our research find that 42% of CNSAb isolates were the IS*Aba*1-*bla*~OXA-23~-like gene; but also, a significant correlation was observed between the presence of IS*Aba*1 upstream of *bla*~OXA-23~-like gene and increasing imipenem MICs (≥16 mg/L). This dissimilarity might be due to differences in the *A. baumannii* strains available for study. Additionally, our finding of high prevalence of IS*Aba*1 sequences upstream of the *bla*~ADC~ among 97% of CNSAb isolates is consistent with previous report from Iran; and indicate that presence of IS*Aba*1 sequences upstream of *bla*~ADC~ played an important role in increasing resistance to cephalosporins (MIC~50~ = 128 mg/L).

However, IC II is the most common strain in the world ([@B31]); and majority of the clinical strains (45%) in this study belong to IC variants. The incidence rate of IC variants observed in this study is similar to previously reported rates of 46% from Sweden and 51% from Iran, and is considerably higher than that in other recent reports, including Iran (3%), Latvia (6%), Romania (15%), Italy (23%) and Norway (28%) ([@B21]; [@B27]; [@B31]). With regard to a previous study ([@B21]) and the study of [@B30], 14 CNSAb isolates showed a new combination of amplicons and were considered in this article as the PCR-based group (G) 15--17. Three of the 6 PCR-based groups in the present study, namely G6, G9, and G10, have been documented in previous studies ([@B30]; [@B6]). Although there are differences among the IC variant types in this study and previous studies in Iran ([@B41]; [@B45]; [@B27]), the IC variants are highly resistant to antibiotics, which suggests that it is conceivable that the MDR phenotype has substantially contributed to their spread in Iran ([@B6]).

The results of this study indicate that, in spite of the high rate of antibiotic resistance determinants in the IC I stains in comparison with the IC variant strains, the IC I strains had lower prevalence. This dissimilarity might be due to the higher frequency of strong biofilm formers in the IC variant strains than in the IC I strains. Several studies proved that, cell adhesiveness and ability to form biofilm were higher in the *bla*~PER-1~ producing isolates ([@B33]), and this is in agreement with the result of this study. The capability to form biofilm and presence of the *bla*~PER~ gene were significantly higher in IC variants. In this study, the IC II had slightly higher susceptibility to antimicrobial agents than other clonal lineage population. This might be due to low-frequency of carbapenem-hydrolyzing class D β-lactamase (CHDL) genes and IS*Aba*1 elements, as well as low ability of biofilm formation in IC II strain as compared to IC I and IC variant stains.

It has been clearly shown that, the high prevalence of class 1 integrons among MDR *A. baumannii* clinical isolates is responsible for several nosocomial outbreaks globally ([@B32]). The resistance rates to all the tested antibiotics, except colistin, tigecycline, minocycline, and tetracycline, of the collected CNSAb isolates were \>65%. However, the presence of integron cassette arrays cannot be responsible for all these resistance phenotypes. In Iran, class 1 integrons have been reported previously in \>11% of *A. baumannii* isolates ([@B40]; [@B28]). In the current study, 84% of isolates contain class 1 integrons, but no class 2 and class 3 integrons was detected. This result shows that class 2 and class 3 integrons are not the major resistant determinants in CNSAb isolates in this study, which is consistent with previous studies ([@B40]; [@B28]).

Only six categories of gene cassettes, including aminoglycoside-modifying enzymes, chloramphenicol-resistant, trimethoprim/sulfamethoxazole-resistant, and rifampicin-resistant were detected in spite of previous studies reporting integrons carrying carbepenemase genes ([@B28]). This result indicates that acquisitions of carbapenem-hydrolyzing β-lactamase genes plays more important role than the class 1 integrons in carbapenem resistance in CNSAb. The class 1 integrons rate (84%) here defined for a referral burn center in central Iran is higher than the rates found in other geographical regions, including Western Iran (11%) ([@B48]), China (74%) ([@B53]) and European countries in general (43%) ([@B13]). This result is similar to that of previous studies from the Northwest and center of Iran ([@B40]; [@B28]). From literature survey, this is the first study to report carriage of class 1 integrons and associated arrays in *A. baumannii* isolates from burn patients in Iran.

Analysis of the integron cassette arrays shows that most class 1 integrons include the globally distributed *aac*A4-*cat*B8-*aad*A1 array ([@B31]), and the cassette array *aacC1-orfX-orfX'-aadA1* has been documented in previous studies in Iran ([@B28]). Moreover, gene cassettes encoding aminoglycoside- resistance are present in the majority of CNSAb isolates in this study, suggesting a close relationship between high-level resistance rate to aminoglycoside compounds such as gentamicin and amikacin and the *A. baumannii* isolates. The different types of gene cassette array in this study and previous studies in Iran ([@B28]; [@B48]), suggests that a geographical feature plays a major role in MDR isolates formation, and it could be due to different volumes and patterns of antibiotic consumption in distinct areas. In addition, the results of this study indicate that strains indistinguishable from each other by MLST and MLVA typing can have different cassette arrays, indicating that some of these may be transmitted very efficiently. In this study, amikacin resistance recorded in 10% of the CNSAb isolates was not cassette-encoded. Analysis of the integron cassette arrays show that 50% of these isolates harbor an integron without aminoglycoside resistance genes. In the cases where the class 1 integrons could not be amplified, there were no integrons and alteration of the primer binding site or a large size of the Integron are the most likely explanations for the negative result of PCRs.

According to the findings of this research, MLVA could identify closely epidemiologically related isolates clustered by MLST in some cases (**Figure [1](#F1){ref-type="fig"}**). In this study, isolates with the same ST, such as ST118, have closely related MLVA type (MTs) (**Figure [1](#F1){ref-type="fig"}**). This result suggests that the evaluation of MLVA in CNSAb isolates shows its great ability for discrimination of genetically closely related isolates.

In agreement with previous studies ([@B27]), the present results substantiated that CC92 represented the recent widely distributed clone in Iran, accounting for 52.2% of CNSAb isolates examined in this study. This most likely indicates that the isolates belonging to CC92 might benefit with respect to acquiring resistance determinants and surviving in the health care environment, when encountering selection by antibiotics such as carbapenems. The international spread of the CC92 isolates has been reported from all around the world ([@B30]). This study revealed that the 28 isolates belonging to this lineage were shown to be heterogeneous by MLVA (22 MTs), followed by MLST (13 STs). The 69 CNSAb isolates were shown to be heterogeneous by MLVA (56 MTs) and MLST (40 STs). Taken together, genetic diversity and wide dissemination clones among CNSAb isolates is consistent with recent studies from Iran that show high diversity of STs in *A. baumannii* isolates from burned patients ([@B27]), which are the evidence of dynamic population structure and evolution in progress. The referral of patients from other medical centers of Iran to the hospital in Tehran could be among the possible reasons for this diversity and failure to colonize a specific type. Spread of specific clonally related isolates could have been prevented by the success of infection control programs in the teaching hospital in Iran.

Conclusion
==========

Evidence that XDR-CNSAb from burned patients in Iran is rapidly changing toward growing resistance to various antimicrobials, including tigecycline was presented. Despite the increasing resistance to several first-line antimicrobials, all resistant CNSAb isolates remain sensitive to the antimicrobial colistin, a viable agent in controlling XDR-CNSAb outbreaks, especially in developing countries. This is the first study to perform IC analysis and gene cassette mapping of class integrons of *A. baumannii*, obtained from burned patients in Iran. It can be confirmed that the dominant local IC is an IC variant, with the likelihood that G9 is the predominant member. In the current study, the *aac*A4-*cat*B8-*aad*A1 gene cassette array which confers resistance to aminoglycoside and chloramphenicol was identified as the predominant cassette array of class 1 integrons in CNSAb. This study described the widest distribution of *bla*~OXA-23~-like-horbering IC ST118 (CC92) and ST405 (CC405) were the principal reason for the rapid increase in the carbapenem resistance rate in burned patients in Iran. The findings highlight the importance of an international drug resistance and molecular epidemiology monitoring network of *A. baumannii* isolates to effect global control measures against XDR-CNSAb.
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